CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Published:2022-10 Issue:4 Volume:163 Page:950-964
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ma Christopher^ORCID,Hanzel Jurij,Panaccione Remo,Sandborn William J.,D’Haens Geert R.,Ahuja Vineet,Atreya Raja,Bernstein Charles N.,Bossuyt Peter,Bressler Brian,Bryant Robert V.,Cohen Benjamin,Colombel Jean-Frederic,Danese Silvio,Dignass Axel,Dubinsky Marla C.,Fleshner Phillip R.,Gearry Richard B.,Hanauer Stephen B.,Hart Ailsa,Kotze Paulo Gustavo,Kucharzik Torsten,Lakatos Peter L.,Leong Rupert W.,Magro Fernando,Panés Julian,Peyrin-Biroulet Laurent,Ran Zhihua,Regueiro Miguel,Singh Siddharth,Spinelli Antonino,Steinhart A. Hillary,Travis Simon P.,van der Woude C. Janneke,Yacyshyn Bruce,Yamamoto Takayuki,Allez Matthieu,Bemelman Willem A.,Lightner Amy L.,Louis Edouard,Rubin David T.,Scherl Ellen J.,Siegel Corey A.,Silverberg Mark S.,Vermeire Severine,Parker Claire E.,McFarlane Stefanie C.,Guizzetti Leonardo,Smith Michelle I.,Vande Casteele Niels,Feagan Brian G.,Jairath Vipul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Newer biologic and small-molecule therapies for inflammatory bowel disease;Baumgart;N Engl J Med,2021

2. Evolution of the randomized controlled trial in inflammatory bowel disease: current challenges and future solutions;Khanna;Inflamm Bowel Dis,2018

3. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial;Colombel;Lancet,2017

4. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial;Khanna;Lancet,2015

5. Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis;Yoon;Gastroenterology,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study;Digestive and Liver Disease;2024-01

2. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease;Clinical Gastroenterology and Hepatology;2024-01

3. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators;Inflammatory Bowel Diseases;2023-12-27

4. To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease;Expert Review of Gastroenterology & Hepatology;2023-12-02

5. Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation;Frontline Gastroenterology;2023-11-10